Will you have Short-term memory loss with Sandostatin lar - from FDA reports
Short-term memory loss is found among people who take Sandostatin lar, especially for people who are female, 60+ old , have been taking the drug for 2 - 5 years, also take medication Sandostatin, and have Neuroendocrine tumor. This study is created by eHealthMe based on reports of 21,554 people who have side effects when taking Sandostatin lar from FDA, and is updated regularly.
eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.
eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.
The information that eHealthMe collects includes:
- Side effects (including severity and how people recover from them)
- Associated conditions or symptoms
- Drug effectiveness
- Demographic data regarding drug use
How the study uses the data?
The study is based on octreotide acetate (the active ingredients of Sandostatin lar) and Sandostatin lar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Short-term memory loss are also considered in the study.
What is Sandostatin lar?
Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. (latest outcomes from Sandostatin lar 21,605 users)
What is Short-term memory loss?
Short-term memory loss has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol (latest reports from 142,874 Short-term memory loss patients).
How to use the study?
Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.
21,554 people reported to have side effects when taking Sandostatin lar.
Among them, 582 people (2.7%) have Short-term memory loss
Number of reports submitted per year:
Time on Sandostatin lar when people have Short-term memory loss *:
- < 1 month: 12.7 %
- 1 - 6 months: 15.87 %
- 6 - 12 months: 4.76 %
- 1 - 2 years: 15.87 %
- 2 - 5 years: 28.57 %
- 5 - 10 years: 14.29 %
- 10+ years: 7.94 %
Gender of people who have Short-term memory loss when taking Sandostatin lar *:
- female: 64.84 %
- male: 35.16 %
Age of people who have Short-term memory loss when taking Sandostatin lar *:
- 0-1: 0.0 %
- 2-9: 0.32 %
- 10-19: 0.0 %
- 20-29: 0.95 %
- 30-39: 3.49 %
- 40-49: 9.21 %
- 50-59: 18.73 %
- 60+: 67.3 %
Top conditions involved for these people *:
- Neuroendocrine Tumor: 124 people, 21.31%
- High Blood Pressure: 85 people, 14.60%
- Carcinoid Tumor: 68 people, 11.68%
- High Blood Cholesterol: 43 people, 7.39%
- Pain: 30 people, 5.15%
- Thyroid Diseases: 26 people, 4.47%
- Diabetes: 26 people, 4.47%
- Depression: 23 people, 3.95%
- Sleep Disorder: 21 people, 3.61%
- Pancreatic Neuroendocrine Tumor: 18 people, 3.09%
Top co-used drugs for these people *:
- Sandostatin: 55 people, 9.45%
- Synthroid: 52 people, 8.93%
- Metformin: 32 people, 5.50%
- Afinitor: 30 people, 5.15%
- Amlodipine: 28 people, 4.81%
- Calcium: 17 people, 2.92%
- Oxazepam: 16 people, 2.75%
- Lipitor: 16 people, 2.75%
- Dostinex: 16 people, 2.75%
- Morphine: 16 people, 2.75%
Top other side effects for these people *:
- Diarrhea: 214 people, 36.77%
- Malaise (a feeling of general discomfort or uneasiness): 202 people, 34.71%
- Fatigue (feeling of tiredness): 196 people, 33.68%
- Weight Decreased: 195 people, 33.51%
- Weakness: 183 people, 31.44%
- High Blood Pressure: 183 people, 31.44%
- Nausea (feeling of having an urge to vomit): 164 people, 28.18%
- Pain: 136 people, 23.37%
- Nausea And Vomiting: 131 people, 22.51%
- Abdominal Pain: 129 people, 22.16%
* Approximation only. Some reports may have incomplete information.
Do you have Short-term memory loss while taking Sandostatin lar?
- Check whether a drug or a condition causes Short-term memory loss
- Subscribe to monitor Short-term memory loss in Sandostatin lar
You are not alone:
- Connect with people like you who take Sandostatin lar and have Short-term memory loss
- Use your healthcare experience to help people like you, and be rewarded
Related publications that referenced our studies
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin® LAR® depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2013 Jan .
Drugs that are associated with Short-term memory lossShort-term memory loss (3,351 drugs)
Could your condition cause Short-term memory lossShort-term memory loss (3,473 conditions)
Sandostatin lar side effects
- Sandostatin lar side effects (21,574 reports)
Browse side effects by gender and age
Browse all side effects of Sandostatin lara b c d e f g h i j k l m n o p q r s t u v w x y z
What would happen?
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
Recent general studies
- Will you have Nonspecific Back Pain with Monoket? - now
- Will you have Bacterial Iritis with Norgestimate And Ethinyl Estradiol? - now
- Will you have Back Pain - Nonspecific with Monoket? - now
- Will you have Pain - Back with Monoket? - now
- Will you have Heart Murmurs And Other Sounds with Effexor? - now
- Will you have Japan Coma Scale Abnormal with Fragmin? - 4 seconds ago
- Will you have Unipolar Depression with Glyburide? - 5 seconds ago
- What to expect when you take Niacin and Methotrexate Sodium - 5 seconds ago
- Will you have Major Depressive Disorder with Glyburide? - 5 seconds ago
- Will you have Depression - Major with Glyburide? - 5 seconds ago
Recent personal studies
- A study for a 80 year old man who takes Diovan Hct - 54 minutes ago
- A study for a 49 year old woman who takes Viibryd - an hour ago
- A study for a 56 year old woman who takes Aldactone, Cozaar, Norvasc - an hour ago
- A study for a 63 year old man who takes Horizant, Protonix, Diazepam, Lipitor, Metoprolol Tartrate, Adderall, Lexapro - an hour ago
- A study for a 62 year old woman who takes Allopurinol - an hour ago
- A study for a 52 year old man who takes Testosterone - an hour ago
- Drug comparison of Seroquel, Valium for a 42 year old woman - 2 hours ago
- A study for a 26 year old woman who takes Protonix, Synthroid, Zoloft, Topiramate, Nuvaring, Wellbutrin - 3 hours ago
- A study for a 26 year old woman who takes Lithium Carbonate, Risperidone - 3 hours ago
- A study for a 56 year old man who takes Apple Cider Vinegar, Benazepril Hydrochloride - 3 hours ago
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.